Multiparametric MRI for prostate cancer: Seeing is believing
Menée sur 175 patients avec suspicion de cancer de la prostate, cette étude met en évidence la supériorité de l'IRM multiparamétrique sur le modèle mathématique "Prostate Cancer Prevention Trial risk calculator for high-grade" pour identifier les patients atteints de la maladie
Salami and colleagues present an evaluation of multiparametric magnetic resonance imaging (MRI) combined with MRI/ultrasound fusion prostate biopsies compared with the Prostate Cancer Prevention Trial High-Grade nomogram to predict the presence of clinically significant disease in a largely referral-based population of men. Their report echoes a growing chorus of studies suggesting the ability of MRI and image-guided biopsies to improve the identification of men with clinically significant disease.
Cancer , éditorial, 2013